1738
236
173
107
103
85
69
64
62
54
53
45
44
40
39
39
35
35
32
32
31
31
29
28
27
26
24
23
20
19
18
18
18
17
17
16
15
14
13
13
12
12
12
11
11
10
10
10
9
9
8
8
8
7
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
11109
1110
2679
267
2889
288
Journal of The National Comprehensive Cancer Network
HSR26-228: BTK Inhibitor (Bruton Tyrosine Kinase Inhibitor) Plus Anti-CD20 Antibody Therapy Surpasses CIT (Chemoimmunotherapy) in Frontline CLL (Chronic Lymphocytic Leukemia) With Obinutuzumab Drives Deeper Remissions: A Meta-Analysis of Randomized Controlled Trials
PDF的下载单位、IP信息已删除
(2025-6-4)